NS · Healthcare

Shukra Pharmaceuticals Ltd (524632)

Pharmaceuticals & Biotechnology

Shukra Pharmaceuticals Ltd (524632) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $12.81B, P/E ratio is 58.50, net margin is 28.7%, dividend yield is 0.03%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 524632

Market cap

$12.81B

P/E ratio

58.50

Net margin

28.7%

Dividend yield

0.03%

Shukra Pharmaceuticals Ltd (524632) — FAQ

What is Shukra Pharmaceuticals Ltd's market cap?

Shukra Pharmaceuticals Ltd (524632) has a reported market cap of $12.81B (data as of 2026-07-10).

What is 524632's P/E ratio?

The price-to-earnings (P/E) ratio for Shukra Pharmaceuticals Ltd (524632) is 58.50 (data as of 2026-07-10).

Does Shukra Pharmaceuticals Ltd pay a dividend?

Shukra Pharmaceuticals Ltd (524632) shows a reported dividend yield of 0.03%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Shukra Pharmaceuticals Ltd in?

Shukra Pharmaceuticals Ltd (524632) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 524632 listed on?

524632 is listed on NS.

What is Shukra Pharmaceuticals Ltd's net margin?

Shukra Pharmaceuticals Ltd (524632) reports a net margin of 28.7% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)